You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent childhood acute myeloid leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling

Recruiting
  • Recurrent Childhood Acute Myeloid Leukemia
  • +17 more
    • Miami, Florida
      Nicklaus Children's Hospital
    May 13, 2023

    DNA Samples From Acute Lymphoblastic Leukemia or Acute Myeloid

    Completed
    • Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
    • +8 more
    • Laboratory Biomarker Analysis
    • Philadelphia, Pennsylvania
      Childrens Oncology Group
    Jul 12, 2022

    Ex Vivo Drug Sensitivity Testing and Mutation Profiling

    Completed
    • Recurrent Childhood Acute Myeloid Leukemia
    • +13 more
      • Miami, Florida
        Nicklaus Children's Hospital
      Jan 18, 2023

      Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

      Suspended
      • Juvenile Myelomonocytic Leukemia
      • +27 more
      • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
      • +2 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 11, 2023

      Minimal Residual Disease, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Adult Acute Myeloid

      Completed
      • Minimal Residual Disease
      • +3 more
      • Daratumumab
      • +2 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Mar 2, 2022

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Recruiting
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +9 more
      • Duarte, California
        City of Hope Medical Center
      May 19, 2022

      Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)

      Recruiting
      • Leukemia
      • +12 more
      • filgrastim
      • +6 more
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Jan 20, 2022

      Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

      Terminated
      Has Results
      • Acute Biphenotypic Leukemia
      • +29 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Jan 4, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

      Completed
      Has Results
      • Accelerated Phase Chronic Myelogenous Leukemia
      • +23 more
      • Denver, Colorado
      • +2 more
      Jun 17, 2021

      Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With

      Active, not recruiting
      • Adult Acute Lymphoblastic Leukemia in Remission
      • +46 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 10, 2021

      Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 27, 2023

      Hematopoietic and Lymphoid Cell Tumor, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Myeloid Leukemia Trial in Houston

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 31, 2022

      Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Decitabine,

      Active, not recruiting
      • Acute Myeloid Leukemia
      • +5 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Anti-CD33 CAR T-cells
      • Lymphodepletion Therapy
      • Duarte, California
        City of Hope Medical Center
      Jan 3, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Acute Myeloid Leukemia Trial in Antalya

      Recruiting
      • Acute Myeloid Leukemia
        • Antalya, Turkey
          Antalya Training and Research Hospital
        Jul 29, 2023

        Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

        Not yet recruiting
        • Acute Myeloid Leukemia
        • +3 more
        • Cytokine-Induced Memory-like Natural Killer Cells
        • +2 more
        • Boston, Massachusetts
        • +1 more
        Nov 22, 2023

        Acute Myeloid Leukemia Trial (Dasatinib)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • (no location specified)
        Sep 20, 2023

        Acute Myeloid Leukemia Trial in Fuzhou (CLL1/+CD33 CAR-T)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • CLL1/+CD33 CAR-T
        • Fuzhou, Fujian, China
          Fujian Provincial Children's Hospital
        Jul 10, 2023

        Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

        Recruiting
        • Acute Myeloid Leukemia Refractory
        • Acute Myeloid Leukemia, in Relapse
        • anti Tim-3/CD123 CAR-T cell therapy
        • Xuzhou, Jiangsu, China
          Kailin Xu
        Nov 4, 2023

        CBFA2T3-GLIS2-positive Acute Myeloid Leukemia, AML, Childhood, Relapsed Pediatric AML Trial (ELU001)

        Not yet recruiting
        • CBFA2T3-GLIS2-positive Acute Myeloid Leukemia
        • +3 more
        • (no location specified)
        Nov 14, 2022

        Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

        Active, not recruiting
        • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
        • +9 more
        • Sewell, New Jersey
        • +4 more
        Dec 13, 2022

        Patients With Acute Myeloid Leukemia

        Recruiting
        • Acute Myeloid Leukemia, Adult
          • Freiburg, CA, Germany
            Medical Center- University of Freiburg
          Aug 4, 2023

          The Pediatric Acute Leukemia Screening Trial - A Study to Test

          Recruiting
          • Recurrent Acute Lymphoblastic Leukemia
          • +7 more
          • Biospecimen Collection
          • Birmingham, Alabama
          • +144 more
          Jan 30, 2023

          Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

          Active, not recruiting
          • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
          • +2 more
          • Duarte, California
            City of Hope Medical Center
          Jan 4, 2023